PAOG Welcome To Penny Land - Now $0.10?
February 04 2021 - 9:47AM
InvestorsHub NewsWire
February 4, 2021 -- InvestorsHub NewsWire -- via pennymillions -- First PAO Group, Inc, (USOTC:
PAOG), with its proprietary, U.S. Patent backed CBD
pharmaceutical treatment for Chronic Obstructive Pulmonary Disorder
(COPD) called RespRx caught the #BioWar
Reddit trend and the sub penny PPS started to move up.
Then GW Pharma (GWPH) got priced at $7.2 billion for an acquisition
by Jazz Pharmaceuticals (JAZZ) bringing even more attention to PAOG
and now the PPS has broken through $0.01. What’s next? $0.10.
PAOG reaching a $0.10 PPS could happen. The company has revenue.
PAOG just announced it anticipates reporting $50,000 for
Q4 2020 as part of a $300,000 contract. Today the company
announced plans to expand
revenue with the introduction of new CBD Nutraceuticals. And of
course there is the long-term value of a U.S. Patent backed CBD
pharmaceutical.
PAOG has broken through all resistance trading well above all
moving averages and setting new 52-week high records one after
another. Some intermittent profit taking along the way may be the
only thing to make a PPS rise hesitate along the way. If a #BioWar
Reddit type trend continues, even $0,10 could be a number soon in
the rear view mirror.
Source - https://www.pennymillions.com/blog/paog-welcome-to-penny-land-now-010
Other stocks on the move -
PURA,
ALKM, and
USMJ
SOURCE: pennymillions
Alkame (CE) (USOTC:ALKM)
Historical Stock Chart
From Apr 2024 to May 2024
Alkame (CE) (USOTC:ALKM)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Alkame Holdings Inc (CE) (OTCMarkets): 0 recent articles
More Alkame Holdings Inc (PK) News Articles